/
/
/

Nureca Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)331.90
Volume (₹)2,700.00
High (₹)331.90
Upper Circuit349.20
Low (₹)320.10
Lower Circuit316.00
Prev Close332.60
52W High (₹)358.00
Price323.00
52W Low (₹)204.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)318.70 Cr
Div. Yield (%)0.00
PE Ratio73.48
Debt to Equity0.00
Price to Book1.09
Book Value189.44
EPS (TTM)4.55
Face Value10.00
ROE (%)1.11

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
LENSKARTNSE
POLYMEDNSE
MOLBIONSE
QLINE-SMNSE
3BBLACKBIONSE
LAXMIDENTLNSE
OSELDEVICE-SMNSE
NURECA-BENSE
YASHOPTICS-SMNSE
AVIENCE-SMNSE
LTP
1W Low
1W High
Market cap (₹)
683.5+47.35 (7.44%)
640.95
694.80
1,16,821Cr
1727.6-5.4 (-0.31%)
1706.50
1858
17,930Cr
1127.9+33.15 (3.03%)
1035.20
1161.10
13,068Cr
645+96.05 (17.50%)
558
659.75
1,487Cr
1442.5+1.3 (0.09%)
1430
1588.90
1,272Cr
200.18+0.4 (0.20%)
189.45
201
1,094Cr
385-8.7 (-2.21%)
360
398.40
683Cr
323-8.05 (-2.43%)
320.10
348.35
319Cr
121+3.7 (3.15%)
119
128
300Cr
274.9+5.4 (2.00%)
264.70
281.75
148Cr

Key Highlights of Nureca Ltd Balance Sheet

Nureca Ltd balance sheet discloses shareholders' funds of ₹9.54Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹9.54Cr, and the reserves and surplus of the company is ₹167.62Cr.

The company has its non-current liabilities with total liabilities of ₹192.29Cr as of 2026-03-31.

The current liabilities are ₹15.91Cr as of 2026-03-31. At the same time, current assets are ₹111.58Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹3.05Cr and tangible assets of ₹12.29Cr, provided in the Nureca Ltd financial statements.